logo
Plus   Neg
Share
Email

Eli Lilly Announces FDA Approval Of CYRAMZA For New Indication - Quick Facts

Eli Lilly and Company (LLY) announced the FDA has approved CYRAMZA for the treatment of patients with hepatocellular carcinoma who have a high alpha-fetoprotein and have been treated with sorafenib. As a result of the approval of the new indication, FDA has removed the boxed warning from the labeling of CYRAMZA. With the latest approval, the company has now received five FDA approvals for CYRAMZA.

Eli Lilly noted that it has filed applications for marketing authorization in the European Union and Japan for CYRAMZA and regulatory action is expected in mid-2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. is taking necessary precautions including Covid-19 testing for those employees returning to work at its headquarters in Silicon Valley, Bloomberg reported citing people familiar with the process. The company, which opened its main Apple Park office in May bringing back some hardware and software engineers, plans the gradual reopening of the building keeping the coronavirus safeguards. A U.S. appeals court has blocked the sales of Bayer AG's dicamba-based Xtendimax in the United States. The three-judge panel in the U.S. Court of Appeals for the Ninth Circuit ruled that the US Environmental Protection Agency (EPA) overstated the protections and substantially understated or ignored the risks related to the use of dicamba-based herbicides. Tesla Chief Executive Officer Elon Musk has called for a breakup of Amazon after the online retail giant refused to publish an upcoming book about COVID-19. Writer Alex Berenson said on Twitter that Amazon refused to publish his booklet about the coronavirus as it did not comply with the company's guidelines. Berenson is a former New York Times reporter.
Follow RTT